Cargando…

Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief

BACKGROUND: Neuropathic pain is characterized by pain hypersensitivity to innocuous stimuli (tactile allodynia) that is nearly always resistant to known treatments such as non-steroidal anti-inflammatory drugs or even opioids. It has been reported that some antidepressants are effective for treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagata, Kenichiro, Imai, Toshiyasu, Yamashita, Tomohiro, Tsuda, Makoto, Tozaki-Saitoh, Hidetoshi, Inoue, Kazuhide
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680826/
https://www.ncbi.nlm.nih.gov/pubmed/19389225
http://dx.doi.org/10.1186/1744-8069-5-20
_version_ 1782166973274128384
author Nagata, Kenichiro
Imai, Toshiyasu
Yamashita, Tomohiro
Tsuda, Makoto
Tozaki-Saitoh, Hidetoshi
Inoue, Kazuhide
author_facet Nagata, Kenichiro
Imai, Toshiyasu
Yamashita, Tomohiro
Tsuda, Makoto
Tozaki-Saitoh, Hidetoshi
Inoue, Kazuhide
author_sort Nagata, Kenichiro
collection PubMed
description BACKGROUND: Neuropathic pain is characterized by pain hypersensitivity to innocuous stimuli (tactile allodynia) that is nearly always resistant to known treatments such as non-steroidal anti-inflammatory drugs or even opioids. It has been reported that some antidepressants are effective for treating neuropathic pain. However, the underlying molecular mechanisms are not well understood. We have recently demonstrated that blocking P2X(4 )receptors in the spinal cord reverses tactile allodynia after peripheral nerve injury in rats, implying that P2X(4 )receptors are a key molecule in neuropathic pain. We investigated a possible role of antidepressants as inhibitors of P2X(4 )receptors and analysed their analgesic mechanism using an animal model of neuropathic pain. RESULTS: Antidepressants strongly inhibited ATP-mediated Ca(2+ )responses in P2X(4 )receptor-expressing 1321N1 cells, which are known to have no endogenous ATP receptors. Paroxetine exhibited the most powerful inhibition of calcium influx via rat and human P2X(4 )receptors, with IC(50 )values of 2.45 μM and 1.87 μM, respectively. Intrathecal administration of paroxetine produced a striking antiallodynic effect in an animal model of neuropathic pain. Co-administration of WAY100635, ketanserin or ondansetron with paroxetine induced no significant change in the antiallodynic effect of paroxetine. Furthermore, the antiallodynic effect of paroxetine was observed even in rats that had received intrathecal pretreatment with 5,7-dihydroxytryptamine, which dramatically depletes spinal 5-hydroxytryptamine. CONCLUSION: These results suggest that paroxetine acts as a potent analgesic in the spinal cord via a mechanism independent of its inhibitory effect on serotonin transporters. Powerful inhibition on P2X(4 )receptors may underlie the analgesic effect of paroxetine, and it is possible that some antidepressants clinically used in patients with neuropathic pain show antiallodynic effects, at least in part via their inhibitory effects on P2X(4 )receptors.
format Text
id pubmed-2680826
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26808262009-05-13 Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief Nagata, Kenichiro Imai, Toshiyasu Yamashita, Tomohiro Tsuda, Makoto Tozaki-Saitoh, Hidetoshi Inoue, Kazuhide Mol Pain Research BACKGROUND: Neuropathic pain is characterized by pain hypersensitivity to innocuous stimuli (tactile allodynia) that is nearly always resistant to known treatments such as non-steroidal anti-inflammatory drugs or even opioids. It has been reported that some antidepressants are effective for treating neuropathic pain. However, the underlying molecular mechanisms are not well understood. We have recently demonstrated that blocking P2X(4 )receptors in the spinal cord reverses tactile allodynia after peripheral nerve injury in rats, implying that P2X(4 )receptors are a key molecule in neuropathic pain. We investigated a possible role of antidepressants as inhibitors of P2X(4 )receptors and analysed their analgesic mechanism using an animal model of neuropathic pain. RESULTS: Antidepressants strongly inhibited ATP-mediated Ca(2+ )responses in P2X(4 )receptor-expressing 1321N1 cells, which are known to have no endogenous ATP receptors. Paroxetine exhibited the most powerful inhibition of calcium influx via rat and human P2X(4 )receptors, with IC(50 )values of 2.45 μM and 1.87 μM, respectively. Intrathecal administration of paroxetine produced a striking antiallodynic effect in an animal model of neuropathic pain. Co-administration of WAY100635, ketanserin or ondansetron with paroxetine induced no significant change in the antiallodynic effect of paroxetine. Furthermore, the antiallodynic effect of paroxetine was observed even in rats that had received intrathecal pretreatment with 5,7-dihydroxytryptamine, which dramatically depletes spinal 5-hydroxytryptamine. CONCLUSION: These results suggest that paroxetine acts as a potent analgesic in the spinal cord via a mechanism independent of its inhibitory effect on serotonin transporters. Powerful inhibition on P2X(4 )receptors may underlie the analgesic effect of paroxetine, and it is possible that some antidepressants clinically used in patients with neuropathic pain show antiallodynic effects, at least in part via their inhibitory effects on P2X(4 )receptors. BioMed Central 2009-04-23 /pmc/articles/PMC2680826/ /pubmed/19389225 http://dx.doi.org/10.1186/1744-8069-5-20 Text en Copyright © 2009 Nagata et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Nagata, Kenichiro
Imai, Toshiyasu
Yamashita, Tomohiro
Tsuda, Makoto
Tozaki-Saitoh, Hidetoshi
Inoue, Kazuhide
Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief
title Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief
title_full Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief
title_fullStr Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief
title_full_unstemmed Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief
title_short Antidepressants inhibit P2X(4 )receptor function: a possible involvement in neuropathic pain relief
title_sort antidepressants inhibit p2x(4 )receptor function: a possible involvement in neuropathic pain relief
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680826/
https://www.ncbi.nlm.nih.gov/pubmed/19389225
http://dx.doi.org/10.1186/1744-8069-5-20
work_keys_str_mv AT nagatakenichiro antidepressantsinhibitp2x4receptorfunctionapossibleinvolvementinneuropathicpainrelief
AT imaitoshiyasu antidepressantsinhibitp2x4receptorfunctionapossibleinvolvementinneuropathicpainrelief
AT yamashitatomohiro antidepressantsinhibitp2x4receptorfunctionapossibleinvolvementinneuropathicpainrelief
AT tsudamakoto antidepressantsinhibitp2x4receptorfunctionapossibleinvolvementinneuropathicpainrelief
AT tozakisaitohhidetoshi antidepressantsinhibitp2x4receptorfunctionapossibleinvolvementinneuropathicpainrelief
AT inouekazuhide antidepressantsinhibitp2x4receptorfunctionapossibleinvolvementinneuropathicpainrelief